Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

XLY.TO

Strong BuyFull House

Auxly Cannabis Group Inc. · Healthcare · Canada · $232M · Avg Vol: $265K/d

98
StockRank
Get insider-trade alerts
Q
76
V
63
M
73
P/E (TTM)
10.3x
ROE
20.2%
D/E
0.3x
Dividend %
—
Dir. Trades · 180d
None →
Buybacks · 180d
$52.5K →
Loading 1Y...
PRICE (1Y)+26.2%
1.821.952.082.212.33Jul 23Aug 14Sep 4
SMA 50SMA 200

Close
$2.30
RSI (14)
56.9
52W High
$2.38
From 52W High
1.0%

SCORE BREAKDOWN

Quality
76
ROIC
16.5%88.0
ROE
20.2%89.0
GP/Assets
32.2%69.3
Op. Margin
19.0%82.5
FCF/Assets
12.1%90.5
Piotroski
498.0
Int. Cover
7.1x58.0
D/E Ratio
0.29x42.0
Current Ratio
2.35x44.7
Value
63
P/E (TTM)
10.3x87.9
EV/EBITDA
8.6x73.4
P/FCF
9.7x82.5
P/B
24.3x4.8
P/S
2.0x68.2
Div Yield
—N/A
Momentum
73
52W High %
96%95.4
RS 6M
79%95.5
SMA 50/200
1.28x92.6
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-26%14.6
Q Growth
-7%32.7

FUNDAMENTALS

Market Cap
$232M
P/E (Forward)
13.8x
Gross Margin
52.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of XLY.TO are excluded.

TickerCompanyMkt CapStockRankSignal
XLY.TOAuxly Cannabis Group Inc.(you)$232M98Strong Buy
CPH.TOCipher Pharmaceuticals Inc.$265M92Strong Buy
LOVE.TOCannara Biotech Inc.$141M95Strong Buy
RX.VBioSyent Inc.$130M91Strong Buy
MDP.TOMedexus Pharmaceuticals Inc.$118M89Strong Buy
OGI.TOOrganigram Global Inc.$171M66Buy
TSND.TOTerrAscend Corp.$243M60Hold
GUD.TOKnight Therapeutics Inc.$682M76Buy
HLS.TOHLS Therapeutics Inc.$80M66Buy
BHCBausch Health Companies Inc.$2.4B88Strong Buy

Peer medians: ROE -37.9% · P/E 17.7x · Gross margin 44.2%

Auxly Cannabis Group Inc. (XLY.TO): Stock Score Summary

Auxly Cannabis Group Inc. (XLY.TO) has a MoatMap StockRank of 98/100 based on Quality (76/100), Value (63/100), and Momentum (73/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$2.30
Market Cap$232M
P/E (TTM)10.26
P/E (Forward)13.79
Price/Book24.27
Return on Equity20.2%
Return on Invested Capital16.5%
Debt/Equity0.29x
Gross Margin52.9%
Operating Margin19.0%
Revenue Growth18.0%
Free Cash Flow$24M

Auxly Cannabis Group Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Auxly Cannabis Group Inc.’s (XLY.TO) StockRank?
MoatMap’s StockRank for Auxly Cannabis Group Inc. (XLY.TO) is 98/100, with a Strong Buy signal. It is a composite of Quality (76), Value (63), and Momentum (73) factor ranks across MoatMap’s 20,000+ stock universe.
Does Auxly Cannabis Group Inc. have an economic moat?
Auxly Cannabis Group Inc. (XLY.TO) has a Quality factor score of 76/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Auxly Cannabis Group Inc. a buy, hold, or sell?
MoatMap’s current signal for Auxly Cannabis Group Inc. (XLY.TO) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is Auxly Cannabis Group Inc. in?
Auxly Cannabis Group Inc. (XLY.TO) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Canada).
Browse all ranked stocksXLY.TO deep dive reportAI ChampionsHow we score stocksSense-check another stock